Results 51 to 60 of about 6,701,012 (264)
Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis [PDF]
, 2002 Hormone replacement therapy (HRT) increases the risk of venous thrombosis. We investigated whether this risk is affected by carriership of hereditary prothrombotic abnormalities.
A. Rumley +26 more
core +1 more source
Neurological, psychological, and cognitive disorders in patients with chronic kidney disease on conservative and replacement therapy [PDF]
, 2016 Chronic kidney disease (CKD) is a highly prevalent condition in the world. Neurological, psychological, and cognitive disorders, related to CKD, could contribute to the morbidity, mortality, and poor quality of life of these patients.
Aceto, Paola +15 more
core +1 more source
Dysmetabolic Nephropathies in Children
Počki, 2012 This article focuses on the causes leading to dysmetabolic nephropathies and deals with the classification, clinical manifestations and possible complications of the disease. Furthermore, dietary treatment regimens for different types of crystalluria and
S.V. Kushnirenko
doaj +1 more source
Is convention hip precaution necessary after total hip arthroplasty?
Journal of Orthopaedics, Trauma and Rehabilitation, 2021 Background: Dislocation is one of the most common causes of revision after total hip arthroplasty (THA). Standard hip precautions are thought to enhance soft-tissue healing and reduce dislocations.
Vincent WK Chan +4 more
doaj +1 more source
The Controversial History of Hormone Replacement Therapy
Medicina, 2019 The history of hormone replacement therapy (HRT) started in the 1960s, with very high popularity in the 1990s. The first clinical trials on HRT and chronic postmenopausal conditions were started in the USA in the late 1990s. After the announcement of the
A. Cagnacci, M. Venier
semanticscholar +1 more source
Anti-CTLA-4 (CD 152) monoclonal antibody-induced autoimmune interstitial nephritis [PDF]
, 2009 Targeted immune-modulating agents are entering clinical practice in many specialties, providing novel therapeutic possibilities but introducing new potential toxicities.
Clatworthy, Menna R +4 more
core +2 more sources
Clinical Epidemiology and Global HealthBackground: Hemodialysis patients have unique physiological characteristics that necessitate specialized care during the treatment. As the prevalence of kidney disease continues to rise, the importance of addressing the unique needs of these patient ...
Megha Nagaraj Nayak, Veena Natti Krishna
doaj +1 more source
BMJ, 2004 Although products for nicotine replacement therapy (NRT) have been available for over 20 years, they have been excluded until recently from state or insurance based health service provision in the United Kingdom and many other countries. They have therefore not been widely prescribed by doctors who help smokers wanting to quit.
openaire +3 more sources
CAKUT-Syndrome and Chronic Kidney Disease: the Concept of Nephrology Approach
Počki, 2015 This article presents the results of the analysis of the etiological structure of chronic kidney disease (CKD) in Kyiv children from 2006 to 2015. In the structure of CKD, CAKUT-syndrome dominates — from 62.3 % (2013) to 80.8 % (2008), an average of 10 ...
S.V. Kushnirenko
doaj +1 more source
Clinical outcome of a patient with lysosomal acid lipase deficiency and first results after initiation of treatment with Sebelipase alfa: A case report [PDF]
, 2019 We report on a case of very rare autosomal recessive cholesteryl ester storage disease due to lysosomal acid lipase deficiency (LALD). LALD is caused by mutations in the lysosomal acid lipase A (LIPA) gene resulting in cholesteryl ester accumulation in
Bobbert, Thomas +8 more
core +1 more source